Other Information.
−Removed: Our 2024 annual meeting of stockholders will be delayed by more than
−Removed: 30 days from February 3, the anniversary date of the 2023 annual meeting of stockholders.
−Removed: Our board of directors has not yet determined
−Removed: the date of the 2024 annual meeting of stockholders.
−Removed: We will provide all required information about the 2024 annual meeting of stockholders
−Removed: when it becomes available.
+Added: 2024 annual meeting of stockholders will be delayed by more than 30 days from February 3, the anniversary date of the 2023 annual meeting
+Added: of stockholders.
+Added: On July 25, 2024, our board of directors, acting in accordance with the authority granted to our board of directors
+Added: pursuant to the applicable provisions of our bylaws, elected to postpone the 2024 annual meeting of stockholders to a date to be determined
+Added: by our board of directors in accordance with the applicable provisions of our bylaws.
+Added: Our board of directors has not yet determined the
+Added: date of the postponed 2024 annual meeting of stockholders.
+Added: We will provide all required information about the postponed 2024 annual meeting
+Added: of stockholders when it becomes available.
the Exhibit Index to this Quarterly Report immediately below and before the signature page hereto, which Exhibit Index is incorporated
by reference as if fully set forth herein.
−Removed: Incorporated by Reference
−Removed: Exhibit Description
+Added: Exhibit Number
Certificate of Incorporation
8 unchanged sentences
June 28, 2023
+Added: Fifth Certificate of Amendment to Certificate of Incorporation of Allarity Therapeutics, Inc.
+Added: April 4, 2024
Specimen Common Stock Certificate of Allarity Therapeutics, Inc.
5 unchanged sentences
July 11, 2022
−Removed: Seventh Certificate of Amendment (Series A Preferred Stock)
−Removed: March 15, 2024
−Removed: Senior Convertible Note, dated as of March 14, 2024
−Removed: March 15, 2024
−Removed: Sixth Certificate of Amendment (Series A Preferred Stock)
−Removed: February 14, 2024
−Removed: Senior Convertible Note, dated as of February 13, 2024
−Removed: February 14, 2024
−Removed: Fifth Certificate of Amendment (Series A Preferred Stock)
−Removed: January 19, 2024
−Removed: Senior Convertible Note
−Removed: January 19, 2024
−Removed: At-The-Market Issuance Sales Agreement, dated March 19, 2024, by and between Allarity Therapeutics, Inc.
−Removed: and Ascendiant Capital Markets, LLC
−Removed: March 20, 2024
−Removed: Amendment Senior Convertible Notes
−Removed: March 1, 2024
−Removed: Limited Waiver Agreement, dated as of February 13, 2024, by and between the Company and the Purchaser listed on the signature page attached thereto
−Removed: February 14, 2024
−Removed: Amendment to Securities Purchase Agreement, dated as of January 25, 2024, by and between the Company and the Purchaser listed on the signature page attached thereto
−Removed: January 25, 2024
−Removed: Securities Purchase Agreement, dated as of January 18, 2024, by and between the Company and the Purchaser listed on the signature page attached thereto
−Removed: January 19, 2024
−Removed: Consulting Agreement (James G.
−Removed: Confidential Settlement Agreement and General Release (James G.
−Removed: Allarity Therapeutics, Inc.
−Removed: 2021 Equity Incentive Plan (as amended and restated as of March 7, 2024)
−Removed: March 8, 2024
+Added: First Comprehensive Amendment to At-The-Market Issuance Sales Agreement, dated May 17, 2024
+Added: Management Services Agreement, effective as of June 1, 2024
Certifications of the Chief Executive Officer under Section 302 of the Sarbanes-Oxley Act
2 unchanged sentences
Certifications of the Chief Financial Officer under Section 906 of the Sarbanes-Oxley Act
−Removed: Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
+Added: Inline XBRL Instance Document (the instance document
+Added: does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
Inline XBRL Taxonomy Extension Schema Document.
−Removed: Inline XBRL Taxonomy Extension Calculation Linkbase Document.
−Removed: Inline XBRL Taxonomy Extension Definition Linkbase Document.
+Added: Inline XBRL Taxonomy Extension Calculation Linkbase
+Added: Inline XBRL Taxonomy Extension Definition Linkbase
Inline XBRL Taxonomy Extension Label Linkbase Document.
−Removed: Inline XBRL Taxonomy Extension Presentation Linkbase Document.
−Removed: Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
−Removed: of the exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601.
−Removed: The Registrant agrees
−Removed: to furnish a copy of all omitted exhibits and schedules to the SEC upon its request.
−Removed: management contract or compensatory plan or arrangement.
+Added: Inline XBRL Taxonomy Extension Presentation Linkbase
+Added: Cover Page Interactive Data File (formatted as inline
+Added: XBRL and contained in Exhibit 101)
+Added: Certain of the exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601.
+Added: The Registrant agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request.
+Added: Indicates management contract or compensatory plan or arrangement.
Furnished herewith.
2 unchanged sentences
THERAPEUTICS, INC.,
−Removed: Chief Executive Officer
+Added: Chief Executive
(Principal Executive Officer)
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.